Aurobindo Pharma

 
Home Investor Relations Investors Share Performance
   
   
   
Share Performance
Month NSE BSE
High Low Volume High Low Volume
Apr-13 194.00 146.85 5,12,73,659 194.00 147.00 91,86,070
Mar-13 170.40 127.15 3,94,79,514 170.30 127.15 48,69,332
Feb-13 195.90 157.90 4,44,70,590 195.80 158.15 72,11,700
Jan-13 204.90 178.70 3,94,84,810 204.90 178.80 53,36,427
Dec-12 201.40 181.75 4,33,70,039 201.40 181.10 58,46,567
Nov-12 189.90 158.90 5,52,61,469 189.85 159.00 87,21,672
Oct-12 164.80 136.10 3,89,56,132 164.75 136.15 70,70,855
Sep-12 144.90 111.15 4,46,65,832 144.75 111.15 86,31,155
Aug-12 116.20 101.30 2,49,87,896 117.45 99.65 47,46,968
Jul-12 118.25 100.10 1,50,04,921 118.20 100.35 24,66,779
Jun-12 111.90 103.65 1,87,23,620 111.75 103.00 22,74,135
May-12 134.30 100.50 2,86,67,618 132.50 100.75 33,01,707
Apr-12 141.40 109.00 3,17,13,528 141.15 102.25 56,28,069
Mar-12 124.80 108.20 2,86,32,211 124.80 108.10 51,69,924
Feb-12 124.40 101.05 3,25,39,982 124.50 101.05 70,35,585
Jan-12 116.15 85.40 2,57,56,470 115.95 85.05 44,34,277
Dec-11 98.30 83.05 1,92,32,059 98.50 83.35 12,44,664
Nov-11 132.80 80.15 3,84,15,525 132.80 80.35 77,54,072
Oct-11 137.40 118.00 1,32,26,110 136.40 116.55 10,86,492
Sep-11 144.90 123.00 2,17,57,540 144.30 123.05 10,78,323
Aug-11 174.40 122.50 3,18,22,146 173.85 122.65 10,79,703
July-11 188.90 164.05 2,42,43,535 188.85 164.80 13,28,727
June-11 185.00 164.75 1,97,20,703 184.90 164.70 13,57,951
May-11 197.70 158.60 3,22,12,237 197.65 160.45 10,49,550
Apr-11 206.00 188.70 1,82,29,528 206.00 189.00 10,36,530
Mar-11 209.55 171.45 5,49,51,274 209.40 171.70 9,92,413
Feb-11 246.35 156.20 4,75,31,120 244.50 156.50 1,16,10,490
Jan-11 1376.95 1151.35 29,71,034 1375.00 1125.00 2,52,670
Dec-10 1347.30 1195.10 29,53,923 1349.00 1195.00 3,06,291
Nov-10 1350.00 1161.05 3,569,069 1349.00 1160.00 241,935
Oct-10 1223.00 1039.80 37,29,320 1221.90 1040.00 4,23,295
Sep-10 1108.95 1023.05 4,536,356 1110.00 1022.10 518,176
Aug-10 1100.15 927.00 7,264,150 1109.85 927.00 719,741
Jul-10 1018.00 897.00 29,85,022 1017.00 898.00 4,65,751
Jun-10 934.80 793.00 41,14,674 926.80 793.40 7,10,699
May-10 959.05 825.00 26,84,190 959.00 786.25 2,08,862
Apr-10 988.20 882.72 17,00,684 986.00 919.50 2,29,545
Mar-10 989.90 916.90 40,78,074 990.00 886.10 5,46,769
Feb-10 954.40 855.00 4,041,466 973.70 843.00 600,001
Jan-10 944.90 810.00 3,503,488 939.00 812.30 387,123
Dec-09 931.85 842.00 4,151,670 930.50 850.10 694,073
Nov-09 884.00 735.25 3,934,882 883.40 735.00 760,649
Oct-09 887.80 735.60 41,73,188 891.40 737.50 4,68,641
Sep-09 794.75 660.00 29,85,034 794.00 672.05 7,65,854
Aug-09 725.00 512.65 36,77,334 723.00 573.00 8,60,242
Jul-09 597.80 394.90 57,40,913 579.25 406.00 16,84,256
Jun-09 529.00 374.00 44,09,220 528.00 374.00 12,73,007
May-09 394.40 225.10 53,41,812 393.00 225.00 18,12,585
Apr-09 256.15 175.55 25,21,571 256.25 181.60 6,32,680
Mar-09 192.85 141.70 33,50,519 200.00 144.05 12,44,882
Feb-09 163.90 126.25 36,75,807 160.10 126.50 17,54,176
Jan-09 182.45 130.50 26,20,922 182.75 134.05 8,02,666
Dec-08 172.25 104.00 40,91,219 171.20 103.20 17,94,192
Nov-08 142.35 101.25 52,90,683 136.00 101.60 22,05,344
Oct-08 284.00 125.00 25,89,321 281.80 124.25 6,09,348
Sep-08 328.10 256.00 12,58,093 327.00 262.25 3,40,579
Aug-08 323.30 275.40 16,17,767 319.95 273.60 4,56,032
Jul-08 310.00 260.10 26,16,086 315.00 260.00 7,89,517
Jun-08 358.00 260.55 5,605,237 358.00 263.05 2,055,977
May-08 359.95 270.00 3,346,931 360.00 280.10 1,191,646
Apr-08 347.20 283.20 3,075,454 347.00 284.00 1,185,043
Mar-08 347.50 240.65 3,641,288 348.50 241.00 1,185,989
Feb-08 333.00 277.00 4,686,020 332.00 279.00 2,042,649
Jan-08 554.80 223.70 7,366,138 554.05 233.00 2,698,972
Dec-07 557.90 495.05 3,404,180 558.00 495.00 977,991
Nov-07 599.90 485.00 1,635,536 600.00 486.00 589,204
Oct-07 609.75 522.20 2,598,621 609.00 525.75 768,323
Sep-07 646.60 560.00 2,017,642 647.00 579.00 696,047
 
   
   
   

© Copyright 2012 Aurobindo Pharma